Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries

European Journal of Clinical Microbiology and Infectious Diseases - Tập 30 Số 12 - Trang 1587-1593 - 2011
Nubia L. Ramos1,2, Dang Thi Ngoc Dzung3,4, Konrad H. Stopsack4, Viktor Jankó5, Mohammad Reza Pourshafie6, Mohammad Katouli7, Annelie Brauner4
1Karolinska Institutet and Karolinska University Hospital
2University of the Sunshine Coast
3Department of Biochemistry, Hanoi Medical University and Hanoi Medical University Hospital, Hanoi, Vietnam
4Department of Microbiology, Tumour and Cell Biology, Division of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
5Department of Pediatrics, Comenius University Medical School, Bratislava, Slovakia
6Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran
7Faculty of Science, Health and Education, University of the Sunshine Coast, Maroochydore, Australia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chakupurakal R, Ahmed M, Sobithadevi DN, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63:652–654

Williams G, Craig JC (2009) Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 22:72–76

Shaikh N, Morone NE, Bost JE, Farrell MH (2008) Prevalence of urinary tract infection in childhood. Pediatr Infect Dis J 27:302–308

Leroy S, Chalumeau M, Ulinski T, Dubos F, Sergent-Alaoui A, Merzoug V, Ducou-le-Pointe H, Audry G, Gendrel D, Bensman A (2010) Impressive renal damage after acute pyelonephritis in a child. Pediatr Nephrol 25:1365–1368

Conway PH, Cnaan A, Zaoutis T, Henry BV, Grunmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:179–186

Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, Hodson EM, Carapetis JR, Cranswick NE, Smith G, Irwig LM, Caldwell PHY, Hamilton S, Roy LP (2009) Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361:1748–1759

Bitsori M, Maraki S, Kalmanti M, Galanakis E (2009) Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 24:2381–2386

Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E (2009) Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 41:953–957

Cheng C-H, Tsau Y-K, Kuo C-Y, Su L-H, Lin T-Y (2010) Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 29:736–740

Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-M, Schembri MA (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233–3244

Lüthje P, Brauner A (2010) Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. J Clin Microbiol 48:2316–2317

Kai-Larsen Y, Lüthje P, Chromek M, Peters V, Wang X, Holm Å, Kadas L, Hedlund K-J, Johansson J, Chapman MR, Jacobson SH, Römling U, Agerberth B, Brauner A (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6:e1001010

Cooke NM, Smith SG, Kelleher M, Rogers TR (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48:1099–1104

Johnson JR, Brown JJ (1996) A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 173:920–926

Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558

Restieri C, Garriss G, Locas M-C, Dozois CM (2007) Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol 73:1553–1562

Roche AJ, McFadden JP, Owen P (2001) Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology 147:161–169

van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, Groups EARSSGaESoACP (2008) Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 14:1722–1730

Pan Y, Henderson J, Britt H (2006) Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002–03. Respir Med 100:2004–2011

Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132

Mehrgan H, Rahbar M, Arab-Halvaii Z (2010) High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 4:132–138

Duong DV, Binns CW, Le TV (1997) Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health 2:1133–1139

Gaspari RJ, Dickson E, Karlowsky J, Doern G (2006) Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist 12:126–129

Bukh AS, Schønheyder HC, Emmersen JMG, Søgaard M, Bastholm S, Roslev P (2009) Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother 64:163–168

Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190:1739–1744

Narchi H, Al-Hamdani M (2010) Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist 16:151–154

Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299(1):53–63

Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, Kobe B, Beatson SA, Schembri MA (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78(4):1659–1669

Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51:283–296

Lüthje P, Brauner A (2010) Putative link between the virulence-associated gene fluA and fluoroquinolone resistance in uropathogenic E. coli. J Clin Microbiol 48:675–676

Ryu J-H, Beuchat LR (2005) Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl Environ Microbiol 71:247–254

Uhlich G, Cooke PH, Solomon EB (2006) Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 72:2564–2572

Andersson DI (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9:461–465